An analgesic ‘X’ acts through opioid as well as additional spinal monoaminergic mechanisms. Which of the following can be ‘X’?
**Core Concept**
The question is testing the knowledge of analgesics that act through multiple mechanisms, including opioid receptors and spinal monoaminergic pathways. This involves understanding the pharmacological properties of analgesics and their mechanisms of action.
**Why the Correct Answer is Right**
The correct answer is a combination of analgesics that act through opioid receptors as well as spinal monoaminergic mechanisms. This includes drugs like tramadol, which is a weak μ-opioid receptor agonist and also inhibits the reuptake of serotonin and norepinephrine, thereby enhancing the monoaminergic activity in the spinal cord.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because morphine is a pure opioid agonist that acts primarily through μ-opioid receptors and does not have significant monoaminergic activity.
**Option B:** This option is incorrect because buprenorphine is a partial opioid agonist that acts primarily through μ-opioid receptors and does not have significant monoaminergic activity.
**Option C:** This option is incorrect because ketamine is an NMDA receptor antagonist that acts primarily through a different mechanism and does not have significant opioid or monoaminergic activity.
**Option D:** This option is incorrect because diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that acts primarily through the inhibition of cyclooxygenase enzymes and does not have significant opioid or monoaminergic activity.
**Clinical Pearl / High-Yield Fact**
Tramadol is an example of a dual-action analgesic that combines opioid and monoaminergic mechanisms, making it a useful option for managing moderate to severe pain.
**Correct Answer:** C. Ketamine is incorrect, the correct answer is more likely Diclofenac is incorrect, the correct answer is more likely Tramadol